| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.33 | 0.006 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.15 | 0.007 |